NDC 50242-918
TECENTRIQ
Atezolizumab
TECENTRIQ is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Atezolizumab.
| Product ID | 50242-918_0db9ee06-7a81-45f8-862b-b84180b9db13 |
| NDC | 50242-918 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TECENTRIQ |
| Generic Name | Atezolizumab |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2019-03-08 |
| Marketing Category | BLA / BLA |
| Application Number | BLA761034 |
| Labeler Name | Genentech, Inc. |
| Substance Name | ATEZOLIZUMAB |
| Active Ingredient Strength | 840 mg/14mL |
| Pharm Classes | Programmed Death Receptor-1 Blocking Antibody [EPC],Antibodies, Monoclonal, Humanized [CS],Antibodies, Monoclonal [CS],Antibodies [CS],Programmed Death Receptor-1-directed Antibody Interactions [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
Packaging
NDC 50242-918-01
1 VIAL, SINGLE-USE in 1 CARTON (50242-918-01) > 14 mL in 1 VIAL, SINGLE-USE
| Marketing Start Date | 2019-03-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 50242-918-86 [50242091886]
TECENTRIQ INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA761034 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-03-08 |
NDC 50242-918-01 [50242091801]
TECENTRIQ INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA761034 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-03-08 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| ATEZOLIZUMAB | 840 mg/14mL |
Pharmacological Class
- Programmed Death Receptor-1 Blocking Antibody [EPC]
- Antibodies
- Monoclonal
- Humanized [CS]
- Antibodies
- Monoclonal [CS]
- Antibodies [CS]
- Programmed Death Receptor-1-directed Antibody Interactions [MoA]
NDC Crossover Matching brand name "TECENTRIQ" or generic name "Atezolizumab"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50242-917 | TECENTRIQ | atezolizumab |
| 50242-918 | TECENTRIQ | atezolizumab |
Trademark Results [TECENTRIQ]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 TECENTRIQ 86441478 5027722 Live/Registered |
GENENTECH, INC. 2014-10-31 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.